Refine by
Biomarkers And Science Articles & Analysis
26 news found
Additionally, they are compatible with advanced imaging techniques and biomarker analyses, allowing researchers to gather comprehensive data on physiological responses and disease progression. This adaptability not only enhances the robustness of preclinical studies but also fosters collaboration across disciplines, enabling synergies between pharmacology, nutrition, and ...
CD BioGlyco, a leading provider in the field of glycoproteomics, has recently updated its Glycoprotein Quantification Service. This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development. Protein glycosylation, a major post-translational ...
BIOMARK RECEIVES FUNDING SUPPORTING RESEARCH AND DEVELOPMENT PROJECT FOR CANCER TREATMENT MONITORING Vancouver, British Columbia – (February 7th, 2023) – BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), an advanced stage liquid biopsy company with a focus on hard to detect and treat ...
We at BioMark invest in the right science to have trusted clinical outcomes,” says Rashid Bux, CEO of BioMark. ...
Our unique team of experts across neurology, machine learning, and digital biomarker science position us well to execute on our vision to deliver early and accurate brain health measurements and diagnostics to individuals across the ...
VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence data, is introducing a new suite of retrospective data analysis services for clinical trial sponsors in response to growing demand for precision data to optimize lung treatment trials. Announced at the 2022 American Thoracic Society (ATS) International Conference, this suite of services empowers sponsors to leverage ...
Joint research of biomarkers on platform technology of GI Innovation, GI-SMART™, and SpAC9 Pipeline, AI-powered biomarker discovery platform of CellKey Prediction of drug response on next-generation immuno-oncology, personalized cancer treatment effects… increasing reliability and efficiency of treatment GI Innovation, an innovative new drug development company, announced on ...
Joint research of biomarkers on platform technology of GI Innovation, GI-SMARTTM and SpAC9 Pipeline, AI-powered biomarker discovery platform of CellKey Prediction of drug response on next generation immuno-oncology, personalized cancer treatment effects… increasing Reliability and efficiency of treatment GI Innovation, a new innovative drug development company, announced on February ...
About Precision for Medicine Precision for Medicine is the first biomarker-driven clinical research services organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies novel biomarker approaches to clinical research that ...
Integration analysis of multiple sequencing data provides a broader view of the genomics research, which comes extremely handy in gene expression and regulation analysis, biomarker identification, bio-interaction analysis, and more. Based on advanced sequencing technology and an experienced team of scientists, CD Genomics provides high-quality integration analysis solutions to ...
Creative Proteomics, an integrated CRO company committed to providing a full range of services to support various proteome-related research projects from identification of single proteins to large-scale proteomic studies, has recently upgraded its fully-developed Exosome Proteomics Service to identify and quantify the proteins in exosomes. The company can also help discover biomarkers after ...
.: “We are excited to be bringing this best-in-class product to biopharma and biomarker researchers.” Darlene Murphy, Vice President of Commercial Operations, MOBILion Systems Inc., adds: “In 2017, we set our goal to launch at ASMS 2021 in Philadelphia, even with the pandemic delaying ASMS this year, we remained true to the plan and achieved our goals. ...
Creative Biolabs provides label-free proteomics for the discovery of biomarkers, which has overcome the limitation of labeling and quantitative technology in the number of samples and can be implemented in a short experiment period in a flexible and convenient way. ...
Research has reported that exosomes derived from lung cancer are the most promising biomarkers for early diagnosis, prognosis, and treatment of lung cancer. With years of experience in this field, Creative Biolabs provides exosome characterization service and targeted delivery service to advance lung cancer research of global scientists. Exosome ...
The grant covers clinical trial application (CTA)-enabling studies to further characterize the pharmacology and safety of CFTX-1554 and the development of appropriate manufacturing protocols, as well as translational biomarker studies to examine the mechanism of action of AT2R modulation. Paolo Vicini, CDO of Confo Therapeutics, commented: “The additional ...
Thermo Fisher Scientific, the world leader in serving science, today announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca and the University of Nebraska Medical Center as part of its ongoing development of innovative solutions for unmet needs in clinical biomarker discovery. The new alliances ...
Data sharing via this platform will also facilitate objective evaluation of ongoing digital biomarker research projects and development of algorithms that support them. ...
Whether it’s in administration, accounting or product design & manufacturing, Augurex is committed to quality processes that create a solid foundation for our commercialized products, scientific collaborations and pipeline biomarker development. Schedule your meeting with Augurex today Join Augurex with the global rheumatology community and learn about cutting edge ...
Merck, a leading science and technology company, today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva, Switzerland. ...
In addition, we will provide examples how the current platform is ideal for biomarker discovery, biotherapeutics research, antibody and aptamer production, protein analysis, and cellular science. ...